The average volume of the Ad·(ST13)·CEA·E1A(Δ24)-treated SW620 tumors was approximately 170 mm3 at 30 days after treatment, which represented an increase of only 40–70 mm3 compared with the initial tumor volume of 100–130 mm3. The gene discussed is CEACAM5; the disease is neoplasm.